Current Edition

ARC-520

Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of clinical data on ARC-520, the company’s prior generation investigational medicine for the treatment of chronic …

Continue Reading →